National Consensus on the Diagnosis, Risk Stratification and Treatment of Patients with Pulmonary Embolism. Spanish Society of Pneumology and Thoracic Surgery (SEPAR). Society Española Internal Medicine (SEMI). Spanish Society of Thrombosis and Haemostasis (SETH). Spanish Society of Cardiology (ESC)

[1]  Giancarlo Agnelli,et al.  Oral apixaban for the treatment of acute venous thromboembolism. , 2013, The New England journal of medicine.

[2]  M. Monreal,et al.  Low-molecular-weight or unfractionated heparin in venous thromboembolism: the influence of renal function. , 2013, The American journal of medicine.

[3]  S. Adams.  Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism , 2013 .

[4]  S. Goldhaber,et al.  Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. , 2013, The New England journal of medicine.

[5]  G. Raskob,et al.  Apixaban for extended treatment of venous thromboembolism. , 2013, The New England journal of medicine.

[6]  J. Douketis,et al.  Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH) , 2012, Journal of thrombosis and haemostasis : JTH.

[7]  W. Ageno,et al.  Aspirin for preventing the recurrence of venous thromboembolism. , 2012, The New England journal of medicine.

[8]  Christopher D Stave,et al.  American Thoracic Society documents: an official American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline--Evaluation of Suspected Pulmonary Embolism in Pregnancy. , 2012, Radiology.

[9]  Paolo Prandoni,et al.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[10]  Gorka Bastarrika,et al.  CT signs of right ventricular dysfunction: prognostic role in acute pulmonary embolism. , 2011, JACC. Cardiovascular imaging.

[11]  Nathan A. Pugh,et al.  Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial , 2011, The Lancet.

[12]  S. Grifoni,et al.  Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test. , 2011, European heart journal.

[13]  P. Wells,et al.  Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta‐analysis , 2011, Journal of thrombosis and haemostasis : JTH.

[14]  Giancarlo Agnelli,et al.  Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants’ data from seven trials , 2011, BMJ : British Medical Journal.

[15]  P. Razavi,et al.  Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi‐row detector computed tomography scanning , 2011, Journal of thrombosis and haemostasis : JTH.

[16]  M. Prins,et al.  Is extensive screening for cancer in idiopathic venous thromboembolism warranted? , 2011, Journal of thrombosis and haemostasis : JTH.

[17]  R. Yusen,et al.  Risk stratification of normotensive patients with acute symptomatic pulmonary embolism , 2010, British journal of haematology.

[18]  J. Douketis,et al.  Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis , 2010, Journal of thrombosis and haemostasis : JTH.

[19]  R. Yusen,et al.  Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism , 2010, Thorax.

[20]  A. Iorio,et al.  Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. , 2010, Archives of internal medicine.

[21]  Lisa Moores,et al.  Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. , 2010, Archives of internal medicine.

[22]  R. Yusen,et al.  Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism. , 2010, American journal of respiratory and critical care medicine.

[23]  Georg Heinze,et al.  Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism: The Vienna Prediction Model , 2010, Circulation.

[24]  H. Sostman,et al.  Gadolinium-Enhanced Magnetic Resonance Angiography for Pulmonary Embolism , 2010, Annals of Internal Medicine.

[25]  David Anderson,et al.  Subsegmental Pulmonary Embolism Diagnosed by Computed Tomography: Incidence and Clinical Implications. A Systematic Review and Meta-Analysis of the Management Outcome Studies. , 2009 .

[26]  R. Yusen,et al.  Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis. , 2009, Chest.

[27]  O. Dekkers,et al.  Safety of ruling out acute pulmonary embolism by normal computed tomography pulmonary angiography in patients with an indication for computed tomography: systematic review and meta‐analysis , 2009, Journal of thrombosis and haemostasis : JTH.

[28]  T. Overend,et al.  Ambulation after deep vein thrombosis: a systematic review. , 2009, Physiotherapy Canada. Physiotherapie Canada.

[29]  P. Wells,et al.  VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism , 2008, Thrombosis and Haemostasis.

[30]  S. Kahn,et al.  Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy , 2008, Canadian Medical Association Journal.

[31]  F. Klok,et al.  Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis. , 2008, American journal of respiratory and critical care medicine.

[32]  M. Monreal,et al.  Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry , 2008, Thrombosis and Haemostasis.

[33]  L. Trinquart,et al.  Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. , 2008, European heart journal.

[34]  G. Agnelli,et al.  Prognostic Value of Troponins in Acute Pulmonary Embolism: A Meta-Analysis , 2007, Circulation.

[35]  H. Büller,et al.  The natural course of hemodynamically stable pulmonary embolism: Clinical outcome and risk factors in a large prospective cohort study. , 2007, Chest.

[36]  A. Iorio,et al.  D-dimer testing to determine the duration of anticoagulation therapy. , 2006, The New England journal of medicine.

[37]  Michael K Gould,et al.  An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. , 2006, American journal of respiratory and critical care medicine.

[38]  G. Hankey,et al.  Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. , 2006, Archives of internal medicine.

[39]  F. Schiele,et al.  Management of unsuccessful thrombolysis in acute massive pulmonary embolism. , 2006, Chest.

[40]  A. Furber,et al.  Appropriateness of Diagnostic Management and Outcomes of Suspected Pulmonary Embolism , 2006, Annals of Internal Medicine.

[41]  Roslyn A Stone,et al.  Derivation and validation of a prognostic model for pulmonary embolism. , 2005, American journal of respiratory and critical care medicine.

[42]  M. Olschewski,et al.  N-Terminal Pro-Brain Natriuretic Peptide or Troponin Testing Followed by Echocardiography for Risk Stratification of Acute Pulmonary Embolism , 2005, Circulation.

[43]  Paolo Prandoni,et al.  Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. , 2004, The New England journal of medicine.

[44]  J. Eikelboom,et al.  Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. , 2004, Annals of internal medicine.

[45]  M. Gent,et al.  Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. , 2003, The New England journal of medicine.

[46]  P. Ridker,et al.  Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism☆ , 2003 .

[47]  P. Romano,et al.  Comparison of Outcomes after Hospitalization for Deep Venous Thrombosis or Pulmonary Embolism , 2002, Thrombosis and Haemostasis.

[48]  Samuel Z Goldhaber,et al.  Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) , 1999, The Lancet.

[49]  F. Barral,et al.  A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. , 1998, The New England journal of medicine.

[50]  P. Investigators,et al.  Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). , 1990, JAMA.

[51]  F. García-Bragado Dalmau.  [Oral Rivaroxaban for the treatment of symptomatic pulmonary embolism]. , 2013, Revista clinica espanola.

[52]  Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial. , 2012, American heart journal.

[53]  G. Guyatt,et al.  Physicians Evidence-Based Clinical Practice Development : American College of Chest Thrombolytic Therapy Guideline Methodology for Antithrombotic and , 2008 .

[54]  K. L. Lewis,et al.  Multidetector Computed Tomography for Acute Pulmonary Embolism , 2007 .

[55]  M. Huisman,et al.  Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review. , 2006, Chest.

[56]  M. Humbert,et al.  Chronic thromboembolic pulmonary hypertension. , 2004, The European respiratory journal.

[57]  T. Clarkson,et al.  Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. , 2003 .

[58]  A. Geibel,et al.  Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. , 2002, The New England journal of medicine.

[59]  The urokinase pulmonary embolism trial. A national cooperative study. , 1973, Circulation.